⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

November 29, 2025Anticancer Research

Leucine-rich Repeat-containing 15 as a Potential Marker and Therapeutic Target in Cervical Cancer

Thông Dao Thuy Ha Vu

View Full Paper

Ask AI

Bookmark

Share

Abstract

LRRC15 expression is a marker of poorer prognosis in patients with CC, suggesting that LRRC15 represents a potential therapeutic strategy for CC.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Dao et al. (2025) studied this question.

synapsesocial.com/papers/69402de82d562116f2903d87 https://doi.org/10.21873/anticanres.17877

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1LRRC15 Promotes the Development of Breast Cancer by Regulating Autophagy through the PI3K/AKT/mTOR Signaling Pathway2025
2Evaluating LRRC15 as a Dual Prognostic and Therapeutic Biomarker in Glioma 2024
3The Molecular Structure, Expression, and Emerging Role of the 15-Leucine-Rich Repeat Containing Membrane Protein (LRRC15) in Skeletal Biology and DiseasesOriginal Research · 2026
4Pan-cancer analysis of LRRC59 with a focus on prognostic and immunological roles in hepatocellular carcinoma.2024 · 2 citations
5Downregulation of LRRC59 suppresses cervical cancer progression likely by inhibiting YBX1-mediated Wnt/β-catenin signaling.Original Research · 2026